/C O R R E C T I O N -- Berlex, Inc./
July 11 2006 - 9:57PM
PR Newswire (US)
In the news release, New Autoinjection Device Designed to Work With
Betaseron(R) Now Available For Patients With Multiple Sclerosis,
issued earlier today by Berlex, Inc. over PR Newswire, we are
advised by the company that the telephone number for MS Pathways,
should read "1.800.788.1467" rather than "1.800.788.7467" as
originally issued inadvertently. DATASOURCE: Berlex, Inc.
Copyright